Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
This report elaborates on the current development of the Enasidenib industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Celgene Corporation
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
50mg
100mg
Application:
Hospital
Pharmacy
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Enasidenib Industry Overview
-
1.1.1 Enasidenib Market Scope and Market Segments
-
1.1.2 Enasidenib Industry Characteristics
-
1.1.3 Global and China Enasidenib Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Enasidenib Production Value and Growth Rate (2017-2028)
-
1.2 Global Enasidenib Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 50mg
-
1.2.2 100mg
-
1.3 Global Enasidenib Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Pharmacy
-
1.4 Market Analysis by Region
-
1.4.1 North America Enasidenib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Enasidenib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Enasidenib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Enasidenib Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Enasidenib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Enasidenib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Enasidenib Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Enasidenib Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Enasidenib Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Enasidenib Industry Porter's Five Forces Model Analysis
-
2.2.3 Enasidenib Industry PEST Analysis
-
2.3 Enasidenib Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Enasidenib Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Enasidenib Industry
Chapter 3 Global and China Enasidenib Market, by Manufacturer
-
3.1 Global and China Enasidenib Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Enasidenib Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Enasidenib Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Enasidenib Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Enasidenib Market Top 3 Players
Chapter 4 Global and China Enasidenib Market, by Type (2017-2028)
-
4.1 Enasidenib Market Trend, by Type
-
4.2 Global Enasidenib Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Enasidenib Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Enasidenib Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Enasidenib Price Trend, by Type (2017-2028)
-
4.3 China Enasidenib Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Enasidenib Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Enasidenib Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Enasidenib Price Trend, by Type (2017-2028)
Chapter 5 Global and China Enasidenib Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Enasidenib Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Enasidenib Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Enasidenib Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Enasidenib Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Enasidenib Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Enasidenib Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Enasidenib Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Enasidenib Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Enasidenib Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Enasidenib Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Enasidenib Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Enasidenib Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Enasidenib Market Analysis
-
7.1 North America Enasidenib Market, by Type
-
7.2 North America Enasidenib Market, by Application
-
7.3 North America Enasidenib Market Analysis and Forecast, by Country
-
7.3.1 United States Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Enasidenib Market Analysis
-
8.1 Europe Enasidenib Market, by Type
-
8.2 Europe Enasidenib Market, by Application
-
8.3 Europe Enasidenib Market Analysis and Forecast, by Country
-
8.3.1 Germany Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Enasidenib Market Analysis
-
9.1 APAC Enasidenib Market, by Type
-
9.2 APAC Enasidenib Market, by Application
-
9.3 APAC Enasidenib Market Analysis and Forecast, by Country
-
9.3.1 China Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Enasidenib Market Analysis
-
10.1 Latin America, Middle East and Africa Enasidenib Market, by Type
-
10.2 Latin America, Middle East and Africa Enasidenib Market, by Application
-
10.3 Latin America, Middle East and Africa Enasidenib Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Enasidenib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Enasidenib Company Profiles
-
11.1 Celgene Corporation
-
11.1.1 Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Celgene Corporation Enasidenib Product Profiles, Application and Specification
-
11.1.3 Celgene Corporation Enasidenib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Enasidenib Industry Investment Prospect and Risk Assessment
-
12.1 Enasidenib Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Enasidenib Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure China Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Global Enasidenib Production Value and Growth Rate (2017-2028)
-
Figure China Enasidenib Production Value and Growth Rate (2017-2028)
-
Figure Global Enasidenib Market Size and Growth Rate of 50mg (2017-2028)
-
Figure Global Enasidenib Market Size and Growth Rate of 100mg (2017-2028)
-
Figure Global Enasidenib Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Enasidenib Market Size and Growth Rate of Pharmacy (2017-2028)
-
Figure North America Enasidenib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Enasidenib Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Enasidenib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Enasidenib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Enasidenib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Enasidenib Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Enasidenib Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Enasidenib Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Enasidenib Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Enasidenib Market Share, by Manufacturer in 2021
-
Figure Global and China Enasidenib Market Share, by Manufacturer in 2022
-
Table Global Enasidenib Sales Volume, by Type (2017-2028)
-
Table Global Enasidenib Sales Volume Share, by Type (2017-2028)
-
Figure Global Enasidenib Sales Volume Share, by Type (2017-2028)
-
Table Global Enasidenib Sales Value, by Type (2017-2028)
-
Table Global Enasidenib Sales Value Share, by Type (2017-2028)
-
Figure Global Enasidenib Price Trend, by Type (2017-2028)
-
Table China Enasidenib Sales Volume, by Type (2017-2028)
-
Table China Enasidenib Sales Volume Share, by Type (2017-2028)
-
Figure China Enasidenib Sales Volume Share, by Type (2017-2028)
-
Table China Enasidenib Sales Value, by Type (2017-2028)
-
Table China Enasidenib Sales Value Share, by Type (2017-2028)
-
Figure China Enasidenib Price Trend, by Type (2017-2028)
-
Table Global Enasidenib Sales Volume, by Application (2017-2028)
-
Table Global Enasidenib Sales Volume Share, by Application (2017-2028)
-
Figure Global Enasidenib Sales Volume Share, by Application (2017-2028)
-
Table Global Enasidenib Sales Value, by Application (2017-2028)
-
Table Global Enasidenib Sales Value Share, by Application (2017-2028)
-
Figure Global Enasidenib Sales Value Share, by Application (2017-2028)
-
Table China Enasidenib Sales Volume, by Application (2017-2028)
-
Table China Enasidenib Sales Volume Share, by Application (2017-2028)
-
Figure China Enasidenib Sales Volume Share, by Application (2017-2028)
-
Table China Enasidenib Sales Value, by Application (2017-2028)
-
Table China Enasidenib Sales Value Share, by Application (2017-2028)
-
Figure China Enasidenib Sales Value Share, by Application (2017-2028)
-
Figure China Enasidenib Production, Import, Consumption and Export (2017-2022)
-
Figure North America Enasidenib Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Enasidenib Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Enasidenib Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Enasidenib Production, Import, Consumption and Export (2017-2022)
-
Table North America Enasidenib Sales Volume, by Type (2017-2028)
-
Table North America Enasidenib Sales Volume Share, by Type (2017-2028)
-
Figure North America Enasidenib Sales Volume Share, by Type (2017-2028)
-
Table North America Enasidenib Sales Volume, by Application (2017-2028)
-
Table North America Enasidenib Sales Volume Share, by Application (2017-2028)
-
Figure North America Enasidenib Sales Volume Share, by Application (2017-2028)
-
Figure United States Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure United States Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Canada Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Enasidenib Sales Value and Growth Rate (2017-2028)
-
Table Europe Enasidenib Sales Volume, by Type (2017-2028)
-
Table Europe Enasidenib Sales Volume Share, by Type (2017-2028)
-
Figure Europe Enasidenib Sales Volume Share, by Type (2017-2028)
-
Table Europe Enasidenib Sales Volume, by Application (2017-2028)
-
Table Europe Enasidenib Sales Volume Share, by Application (2017-2028)
-
Figure Europe Enasidenib Sales Volume Share, by Application (2017-2028)
-
Figure Germany Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure UK Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure UK Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure France Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure France Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Italy Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Spain Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Poland Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Russia Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Enasidenib Sales Value and Growth Rate (2017-2028)
-
Table APAC Enasidenib Sales Volume, by Type (2017-2028)
-
Table APAC Enasidenib Sales Volume Share, by Type (2017-2028)
-
Figure APAC Enasidenib Sales Volume Share, by Type (2017-2028)
-
Table APAC Enasidenib Sales Volume, by Application (2017-2028)
-
Table APAC Enasidenib Sales Volume Share, by Application (2017-2028)
-
Figure APAC Enasidenib Sales Volume Share, by Application (2017-2028)
-
Figure China Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure China Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Japan Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure India Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure India Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Enasidenib Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Enasidenib Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Enasidenib Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Enasidenib Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Enasidenib Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Enasidenib Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Enasidenib Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Enasidenib Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Enasidenib Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Enasidenib Sales Value and Growth Rate (2017-2028)
-
Table Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Celgene Corporation Product Profiles, Application and Specification
-
Table Celgene Corporation Enasidenib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
